Kaken Pharmaceutical Co - 股票

Kaken Pharmaceutical Co 负债 2024

Kaken Pharmaceutical Co 负债

-46,775 JPY

股票代码

4521.T

ISIN

JP3207000005

在2024年,Kaken Pharmaceutical Co的债务为-46,775 JPY,与前一年-57,175 JPY的总债务相比变动了-18.19%

Kaken Pharmaceutical Co Aktienanalyse

Kaken Pharmaceutical Co在做什么?

Kaken Pharmaceutical Co Ltd is a Japanese pharmaceutical company based in Tokyo. The company was founded in 1949 and has since grown continuously to establish itself as a flagship of the Japanese pharmaceutical industry. The company specializes in the production and sale of prescription and over-the-counter drugs. However, it has also heavily focused on research and development of new medications to expand its market share. Kaken Pharmaceutical's business model is to develop and manufacture high-quality products to ensure they meet the needs and requirements of customers. This includes a wide range of medications, ranging from pain relievers and antiallergics to cosmetic products. The company categorizes its products into five different categories: dermatology, pediatrics, oncology, gastroenterology, and orthopedics. Each of these categories specializes in treating and preventing various diseases, conditions, and complaints, offering a wide range of products. Dermatology is one of the key divisions of Kaken Pharmaceutical. The company offers medications for treating skin conditions such as psoriasis, eczema, dermatitis, and acne. One of its most well-known products is the anti-acne medication Isotretinoin. It works by reducing sebum production, thus reducing inflammation and pore blockage. Kaken Pharmaceutical's pediatrics products focus on treating children. Syrups and drops for symptom relief of colds, coughs, fevers, and diarrhea are among the products offered. In this category, Kaken Pharmaceutical also provides medications for treating children with ADHD. Oncology medications are offered by Kaken Pharmaceutical under the name "Kaken Pharma." These products are intended for the treatment of cancer diseases such as lung, breast, and stomach cancer. The company is constantly striving to improve its research and development to make cancer treatment more effective and efficient. The gastroenterology category focuses on treating digestive disorders such as heartburn, reflux, and gastric ulcers. Kaken Pharmaceutical has introduced several products, including drugs that inhibit stomach acid, which are offered in the form of tablets and granules. Orthopedic medications from Kaken Pharmaceutical are used to treat pain and inflammation of the skeletal system, such as relieving joint pain, arthritis, and osteoporosis. The most well-known product is the pain reliever Ibuprofen, which is available for both oral and topical use. In conclusion, Kaken Pharmaceutical Co Ltd is a company committed to meeting the medical and cosmetic needs of customers. Each product is carefully developed and manufactured to ensure the highest quality and effectiveness. With its wide range of products and research efforts, the company is an important player in the global pharmaceutical market. Kaken Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

负债的详细信息

Kaken Pharmaceutical Co的债务结构理解

Kaken Pharmaceutical Co的总债务是指该公司欠外部各方的累积金融义务。这可能包括短期和长期贷款、债券、贷款和其他金融工具。评估公司的债务对于评估其财务状况,风险概况以及运营和扩展业务的能力至关重要。

年对年对比

通过对Kaken Pharmaceutical Co多年债务结构的分析,可以洞察公司的财务策略和稳定性。债务的减少可能暗示了财务实力和运营效率,而债务的增加可能表明投资增长或潜在的财务挑战。

对投资的影响

投资者会密切关注Kaken Pharmaceutical Co的债务,因为这会影响公司的风险和收益概况。过度的债务可能导致财务压力,而适度并且管理良好的债务可能是增长和扩张的催化剂。这使得债务成为投资评估的重要一环。

债务波动的解读

Kaken Pharmaceutical Co债务水平的变化可能归因为各种运营和策略因素。债务的增加可能旨在资助扩张项目或提高运营能力,而债务的减少可能意味着利润的实现或是一种减小财务风险和杠杆效应的方法。

关于Kaken Pharmaceutical Co股票的常见问题

Kaken Pharmaceutical Co今年的债务有多高?

Kaken Pharmaceutical Co今年的债务水平为-46,775 JPY。

Kaken Pharmaceutical Co的债务与去年相比有多高?

Kaken Pharmaceutical Co的债务与去年相比增长了-18.19% 下降了

Kaken Pharmaceutical Co的投资者高额债务会有什么后果?

对于Kaken Pharmaceutical Co的投资者来说,高额债务可能构成风险,因为它会使公司的财务状况变得较弱,可能会影响其履行义务的能力。

Kaken Pharmaceutical Co的投资者低债务会有什么后果?

低债务意味着Kaken Pharmaceutical Co拥有强大的财务地位,并且能够履行其义务,而不会导致其财务负担过重。

Kaken Pharmaceutical Co的债务增加对公司会有什么影响?

Kaken Pharmaceutical Co的债务增加可能会影响公司的财务状况,从而导致其财务负担增加。

Kaken Pharmaceutical Co的债务减少会对公司产生什么影响?

将Kaken Pharmaceutical Co的债务降低可以增强公司的财务状况并提高其履行财务义务的能力。

Kaken Pharmaceutical Co的债务受哪些因素影响?

影响Kaken Pharmaceutical Co负债的一些因素可能包括投资、收购、运营成本和营业收入的发展。

为什么Kaken Pharmaceutical Co的债务对投资者如此重要?

Kaken Pharmaceutical Co的债务对投资者来说很重要,因为它是公司财务稳定性的指标,并且能向投资者提供有关公司如何履行其财务义务的信息。

Kaken Pharmaceutical Co可以采取哪些战略措施来改变债务状况?

为了改变债务状况,Kaken Pharmaceutical Co可以采取包括削减成本、增加收入、出售资产、接受投资或合作伙伴关系等措施。公司必须对其财务状况进行彻底审查,以确定最佳的战略措施来改变其债务状况。

Kaken Pharmaceutical Co支付多少股息?

在过去的12个月中,Kaken Pharmaceutical Co支付了150 JPY 的股息。这相当于大约4.03 %的股息收益率。在未来的12个月内,Kaken Pharmaceutical Co预计将支付155.09 JPY的股息。

Kaken Pharmaceutical Co的股息收益率有多高?

Kaken Pharmaceutical Co当前的股息收益率为4.03 %。

Kaken Pharmaceutical Co什么时候支付股息?

Kaken Pharmaceutical Co按季度支付股息。这些股息将在, , , 月份分发。

Kaken Pharmaceutical Co的股息有多安全?

Kaken Pharmaceutical Co 在过去23年里每年都支付了股息。

Kaken Pharmaceutical Co的股息有多高?

预计未来12个月的股息将达到155.09 JPY。这相当于4.17 %的股息收益率。

Kaken Pharmaceutical Co位于哪个行业?

Kaken Pharmaceutical Co 被分配到“健康”板块。

Wann musste ich die Aktien von Kaken Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

要获得Kaken Pharmaceutical Co在支付的75 JPY的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

Kaken Pharmaceutical Co最后一次支付股息是什么时候?

上一次股息发放日期为。

Kaken Pharmaceutical Co在2023年的股息是多少?

在2023年,Kaken Pharmaceutical Co 分配了150 JPY作为股息。

Kaken Pharmaceutical Co 的股息是以哪种货币支付的?

Kaken Pharmaceutical Co的股息将以JPY的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

Andere Kennzahlen von Kaken Pharmaceutical Co

我们对Kaken Pharmaceutical Co 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和Kaken Pharmaceutical Co 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: